Accelerating Modern Technology Adoption with CSA

An Axendia Straight from the Source Event

We asked FDA your questions about AI, CSA, and modern technology adoption. Now, we have the answers!

In this Straight from the Source episode, Daniel Matlis sat down with FDA’s Daniel Walter to discuss:

Register to View the Straight from the Source episode.

Why perceived regulatory barriers to modern technology adoption may be less limiting than many companies assume
How CSA helps companies use true risk-based approaches instead of retesting everything by default
Why AI adoption itself is not the issue, but misunderstanding, misapplying, or cutting corners with AI can create risk
How FDA is already using AI tools like ELSA and HALO to summarize documents, navigate SOP banks, and ask more targeted questions
Why “doing nothing” carries risk and may be riskier than modernization

Ready to unlock new opportunities and drive success? Schedule an Analyst Inquiry

Stay Connected with Axendia!

Follow us on LinkedIn: Join our professional network and stay updated on the latest insights, trends, and case studies. Connect with Axendia on LinkedIn
Subscribe to Our Updates: Get exclusive insights and thought leadership articles delivered straight to your inbox. Sign up for our newsletter
Share Your Thoughts: We’d love to hear from you! Contact us to discuss your ideas, challenges, or opportunities. Email Axendia

Stay at the forefront of innovation and technology in life sciences, healthcare, and space-enabled research by connecting with Axendia.

Let’s drive innovation together!

The opinions and analysis expressed in this post reflect the judgment of Axendia at the time of publication and are subject to change without notice. Information contained in this post is current as of publication date. Information cited is not warranted by Axendia but has been obtained through a valid research methodology. This post is not intended to endorse any company or product and should not be attributed as such.